Dopamine β Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.

Adult; Alleles; Dopamine beta-Hydroxylase/genetics; Female; Gene Frequency; Genes, Modifier; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; India; Male; Middle Aged; Parkinson Disease/genetics; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; DBH; Dopaminergic; Neurodegeneration; Norepinephrinergic; Parkinson’s disease

Abstract :

[en] BACKGROUND: Parkinson's disease (PD) is the debilitating movement disorder, distinguished by dopaminergic and norepinephrinergic neurodegeneration. Apart from candidate gene mutations, several modifier loci have been reported to be associated with the disease manifestation. The Dopamine β-Hydroxylase (DBH) maintains cellular dopamine content and regulates dopamine turn over in neurons. Genetic polymorphisms of DBH are associated with PD and are found to alter plasma DBH activity in patients compared to healthy controls. Therefore, DBH activity in plasma could be a potential and easily detectable biomarkers for alteration of dopaminergic neuronal function in PD. METHODS: Plasma DBH activity has been assessed among PD cases and age-matched controls to identify correlation with PD. To elucidate the role of DBH polymorphisms in Eastern Indian PD patients, three SNPs (rs1611115, rs1108580 and rs129882) were selected and screened by PCR-RFLP and DNA sequencing analysis. RESULTS: The T-allele of rs129882 was more prevalent among patients than controls posing risk (p-value = 0.02, OR = 1.404, 95% CI = 1.047-1.883) towards PD. The dual-Luciferase assay in SHSY5Y cell line revealed that the T-allele of rs129882 increases Luciferase signal (p = 0.0269). However, the rs1611115 and rs1108580 did not show association with PD; plasma DBH activity was not significantly different between patients and controls (p-value > 0.05). Haplotypes constructed with three SNPs showed that the CAT haplotype to pose risk, TAC haplotype to provide protection against early disease onset and CGT being protective against non-motor symptoms. CONCLUSION: These data suggest that DBH might influence the susceptibility of PD.

Disciplines :

Genetics & genetic processes

Author, co-author :

Ghosh, Arunibha

Sadhukhan, Tamal

Giri, Subhajit ; Université de Liège - ULiège > Stem Cells-Developmental Neurobiology

Biswas, Arindam

Das, Shyamal Kumar

Ray, Kunal

Ray, Jharna

Language :

English

Title :

Dopamine β Hydroxylase (DBH) is a potential modifier gene associated with Parkinson's disease in Eastern India.

Publication date :

2019

Journal title :

Neuroscience Letters

ISSN :

0304-3940

eISSN :

1872-7972

Publisher :

Elsevier, Netherlands

Volume :

706

Pages :

75-80

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 31 May 2020

Statistics

Number of views

37 (1 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Dauer, W., Przedborski, S., Parkinson's Disease: Mechanisms and Models, Vol. 39, 2003, 889–909.
Lee, M.K., Troncoso, J., Hattori, N., Moore, D.J., Dawson, V.L., Mizuno, Y., Dawson, T.M., Zhang, L., Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14 (2004), 71–84, 10.1093/hmg/ddi007.
Zarow, C., Lyness, S.A., Mortimer, J.A., Chui, H.C., Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60 (2003), 337–341, 10.1001/archneur.60.3.337.
Björklund, A., Shin, E., Carta, M., Rogers, J.T., Devoto, P., Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Exp. Neurol. 257 (2014), 25–38, 10.1016/j.expneurol.2014.04.011.
Bialecka, M., Kurzawski, M., Klodowska-Duda, G., Opala, G., Tan, E.-K., Drozdzik, M., The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Pharmacogenet. Genomics 18 (2008), 815–821, 10.1097/FPC.0b013e328306c2f2.
Das, G., Misra, A.K., Das, S.K., Ray, K., Ray, J., Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians. Neurosci. Lett. 460 (2009), 16–20, 10.1016/j.neulet.2009.05.031.
DeStefano, A.L., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Maher, N.E., Saint-Hilaire, M., Feldman, R.G., Guttman, M., Watts, R.L., Suchowersky, O., Lafontaine, A.L., Labelle, N., Lew, M.F., Waters, C.H., Growdon, J.H., Singer, C., Currie, L.J., Wooten, G.F., Vieregge, P., Pramstaller, P.P., Klein, C., Hubble, J.P., Stacy, M., Montgomery, E., MacDonald, M.E., Gusella, J.F., Myers, R.H., Genome-wide scan for Parkinson's disease: the GenePD study. Neurology 57 (2001), 1124–1126, 10.1212/WNL.57.6.1124.
Sadhukhan, D., Das, G., Biswas, A., Ghosh, S., Das, S.K., Ray, K., Ray, J., Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians. Neurosci. Lett. 675 (2018), 68–73, 10.1016/j.neulet.2018.03.059.
Kim, C.H., Leung, A., Huh, Y.H., Yang, E., Kim, D.J., Leblanc, P., Ryu, H., Kim, K., Kim, D.W., Garland, E.M., Raj, S.R., Biaggioni, I., Robertson, D., Kim, K.S., Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine β-hydroxylase. J. Biol. Chem. 286 (2011), 9196–9204, 10.1074/jbc.M110.192351.
Cho, S., Robertson, D., Cubells, J.F., Kim, K.-S., Zabetian, C.P., Biaggioni, I., Kim, C.-H., Cohen, B.M., Mutations in the dopamine? -hydroxylase gene are associated with human norepinephrine deficiency. Am. J. Med. Genet. 108 (2004), 140–147, 10.1002/ajmg.10196.
Kobayashi, K., Kurosawa, Y., Fujita, K., Nagatsu, T., C.M. Science, volume 17 Number 3 Nucleic Acids Res., 17(1989), 1989.
Kuzuya, H., Dual-Wavelength, Vol. 338, 1974, 320–328.
O'Connor, D.T., Cervenka, J.H., Stone, R.A., Levine, G.L., Parmer, R.J., Franco-Bourland, R.E., Madrazo, I., Langlais, P.J., Robertson, D., Biaggioni, I., Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin. Sci. (Lond) 86 (1994), 149–158 http://www.ncbi.nlm.nih.gov/pubmed/8143425.
Cubells, J.F., Zabetian, C.P., Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurolog. Psychopharmacology (Berl.) 174 (2004), 463–476, 10.1007/s00213-004-1840-8.
Healy, D.G., Abou-sleiman, P.M., Ozawa, T., Bhatia, K., Ahmadi, K.R., Goldstein, D.B., A Functional Polymorphism Regulating Dopamine ␤ -Hydroxylase Influences Against Parkinson's Disease. 2004, 443–446.
Mahata, M., O'Connor, D.T., Chen, Y., Maihofer, A.X., Mustapic, M., Nievergelt, C.M., Baker, D.G., The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter. Hum. Mol. Genet. 23 (2014), 6375–6384, 10.1093/hmg/ddu332.
Zabetian, C.P., Anderson, G.M., Buxbaum, S.G., Elston, R.C., Ichinose, H., Nagatsu, T., Kim, K.S., Kim, C.H., Malison, R.T., Gelernter, J., Cubells, J.F., A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68 (2001), 515–522, 10.1086/318198.
Bhaduri, N., Sarkar, K., Sinha, S., Chattopadhyay, A., Mukhopadhyay, K., Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India. Cell. Mol. Neurobiol. 30 (2010), 265–274, 10.1007/s10571-009-9448-5.
Combarros, O., Warden, D.R., Hammond, N., Cortina-Borja, M., Belbin, O., Lehmann, M.G., Wilcock, G.K., Brown, K., Kehoe, P.G., Barber, R., Coto, E., Alvarez, V., Deloukas, P., Gwilliam, R., Heun, R., Kölsch, H., Mateo, I., Oulhaj, A., Arias-Vásquez, A., Schuur, M., Aulchenko, Y.S., Ikram, M.A., Breteler, M.M., van Duijn, C.M., Morgan, K., Smith, A.D., Lehmann, D.J., The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med. Genet., 11, 2010, 162, 10.1186/1471-2350-11-162.
Punia, S., Das, M., Behari, M., Mishra, B.K., Sahani, A.K., Govindappa, S.T., Jayaram, S., Muthane, U.B., TB, K., Juyal, R.C., Role of polymorphisms in dopamine synthesis and metabolism genes and association of DBH haplotypes with Parkinson's disease among North Indians. Pharmacogenet. Genomics 20 (2010), 435–441, 10.1097/FPC.0b013e32833ad3bb.
Tong, J., McKinley, L., Cummins, T., Johnson, B., Matthews, N., Vance, A., Heussler, H., Gill, M., Kent, L., Bellgrove, M.A., Hawi, Z., Identification and functional characterisation of a novel dopamine beta hydroxylase gene variant associated with attention deficit hyperactivity disorder. World J Biol Psychiatry. 16:8 (2015), 610–618, 10.3109/15622975.2015.1036771 Epub 2015 May 15.
Johns, M.B., Paulus-Thomas, J.E., Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal. Biochem. 180 (1989), 276–278, 10.1016/0003-2697(89)90430-2.
Bhaduri, N., Mukhopadhyay, K., Correlation of plasma dopamine β-hydroxylase activity with polymorphisms in DBH gene: a study on Eastern Indian population. Cell. Mol. Neurobiol. 28 (2008), 343–350, 10.1007/s10571-007-9256-8.
Maniatis, T., Fritsch, E.F., Sambrook, J., Culinary Biol. Cell 61 (1990), 17–18.
Barrett, J.C., Fry, B., Maller, J., Daly, M.J., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005), 263–265, 10.1093/bioinformatics/bth457.
Rodriguez, S., Gaunt, T.R., Day, I.N.M., Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am. J. Epidemiol. 169 (2009), 505–514, 10.1093/aje/kwn359.
Cubells, J.F., Van Kammen, D.P., Kelley, M.E., Anderson, G.M., O'Connor, D.T., Price, L.H., Malison, R., Rao, P.A., Kobayashi, K., Nagatsu, T., Gelernter, J., Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102:5 (1998), 533–540.